We have observed
7 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after June 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
NOVEL POLYMORPHS OF PITAVASTATIN CALCIUM
BINDING DRUGS WITH NANOCRYSTALLINE CELLULOSE (NCC)
PROCESS FOR PREPARING TOLVAPTAN INTERMEDIATES
Yeast-based vaccines as immunotherapy
CELLULOSE-REINFORCED HIGH MINERAL CONTENT PRODUCTS AND METHODS OF MAKING THE SAME
A PROCESS FOR THE PREPARATION OF PAZOPANIB USING NOVEL INTERMEDIATE
Crystalline forms of maraviroc phosphate as intermediates in the preparation of a maraviroc amorphous form